Tuberculosis treatment managed by providers outside the public health department: Lessons for the affordable care act

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Ehman, Melissa ^a,b   Flood, Jennifer ^a   Barry, Pennan M ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; BACTERIUM CULTURE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIRECTLY OBSERVED THERAPY; DRUG ABUSE; FEMALE; HEALTH CARE POLICY; HISPANIC; HOMELESSNESS; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; PRIVATE PRACTICE; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; THERAPY RESISTANCE; TREND STUDY; UNITED STATES; ADOLESCENT; GOVERNMENT; HEALTH CARE PERSONNEL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PUBLIC HEALTH; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALIFORNIA; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PUBLIC HEALTH; TUBERCULOSIS; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES; YOUNG ADULT;

EID: 84908428704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110645     Document Type: Article

References (42)

1. Sbarbaro JA (1970) The public health tuberculosis clinic: its place in comprehensive health care. Am Rev Respir Dis 101: 463-465.
2. Binkin NJ, Vernon AA, Simone P.M., McCray E., Miller BI, et al. (1999) Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services. Int J Tuberc Lung Dis 3: 663-674.
3. Centers for Disease Control and Prevention (2012) Reported Tuberculosis in the United States, 2011. Available at: http://www.cdc.gov/tb/statistics/reports/2011. Accessed on October 31, 2013.
4. Taylor Z, Nolan CM, Blumberg HM (2005) Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 54: 1-81. rr5412a1 [pii].
5. Institute of Medicine (2000) Ending Neglect: The Elimination of Tuberculosis in the United States. Washington, D.C.: National Academy Press.
6. Porco TC, Oh P, Flood JM (2013) Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. Clin Infect Dis 56: 761-769. cis989 [pii]; 10.1093/cid/cis989 [doi].
7. Moonan PK, Quitugua TN, Pogoda J.M., Woo G., Drewyer G, et al. (2011) Does directly observed therapy (DOT) reduce drug resistant tuberculosis? BMC Public Health 11: 19. 1471-2458-11-19 [pii]; 10.1186/1471-2458-11-19 [doi].
8. Weis SE, Slocum PC, Blais F.X., King B., Nunn M, et al. (1994) The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 330: 1179-1184. 10.1056/NEJM199404283301702 [doi].
9. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America (2003) Treatment of tuberculosis. MMWR Recomm Rep 52: 1-77.
10. US Government Printing Office (2012) Public Law 111-148: Patient Protection and Affordable Care Act.
11. U.S. Department of Health and Human Services (2009) U.S. Code of Federal Regulations, 45 CFR 46.101.
12. Centers for Disease Control and Prevention (2003) Report of Verified Case of Tuberculosis (RVCT). CDC 72.9A.
13. Centers for Disease Control and Prevention (2009) Report of Verified Case of Tuberculosis (RVCT). CDC 72.9A.
14. Sprinson JE, Lawton ES, Porco T.C., Flood JM, Westenhouse JL (2006) Assessing the validity of tuberculosis surveillance data in California. BMC Public Health 6: 217.
15. Ehman M, Shaw T, Cass A., Lawton E, Westenhouse J, et al. (2013) Developing and Using Performance Measures Based on Surveillance Data for Program Improvement in Tuberculosis Control. J Public Health Manag Pract 19: E29-E37. 10.1097/PHH.0b013e3182751d6f [doi].
16. Centers for Disease Control and Prevention (2010) Monitoring tuberculosis programs - National Tuberculosis Indicator Project, United States, 2002-2008. MMWR Morb Mortal Wkly Rep 59: 295-298. mm5910a3 [pii].
17. National Cancer Institute (2013) Joinpoint Regression Program, Version 4.0.4. Available at: http://srab.cancer.gov/joinpoint. Accessed on October 31, 2013.
18. Kim HJ, Fay MP, Feuer E.J., Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19: 335-351. 10.1002/(SICI)1097-0258(20000215)19:3,335:AID-SIM336.3.0.CO; 2-Z [pii].
19. SAS Institute Inc. (2012) SAS, version 9.3 [Software].
20. McNutt LA, Wu C, Xue X., Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157: 940-943.
21. Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702-706.
22. Pan W (2001) Akaike's information criterion in generalized estimating equations. Biometrics 57: 120-125.
23. California Department of Public Health, California Tuberculosis Controller's Association (2011) Guidelines for Directly Observed Therapy Program Protocols in California. http://www.ctca.org/fileLibrary/file-347-pdf.
24. Tuberculosis Control Branch (2013) Report on Tuberculosis in California, 2012. http://www.cdph.ca.gov/data/statistics/Pages/TuberculosisDiseaseData-aspx.
25. Golub JE, Bur S, Cronin W.A., Gange S., Baruch N, et al. (2005) Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state. Int J Tuberc Lung Dis 9: 992-998.
26. Liu Z, Shilkret KL, Finelli L (1998) Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995. Chest 113: 1446-1451.
27. Liu Z, Shilkret KL, Ellis HM (1999) Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med 159: 1110-1116.
28. Rao SN, Mookerjee AL, Obasanjo O.O., Chaisson RE (2000) Errors in the treatment of tuberculosis in Baltimore. Chest 117: 734-737.
29. Richardson NL (2000) Evaluating provider prescribing practices for the treatment of tuberculosis in Virginia, 1995 to 1998: an assessment of educational need. J Contin Educ Health Prof 20: 146-155. 10.1002/chp.1340200303 [doi].
30. Silin M, Laraque F, Munsiff S.S., Crossa A., Harris TG (2010) The impact of monitoring tuberculosis reporting delays in New York City. J Public Health Manag Pract 16: E09-E17. 10.1097/PHH.0b013e3181c87ae5 [doi]; 00124784-201009000-00018 [pii].
31. Kong DG, Watt JP, Marks S, Flood J (2013) HIV status determination among tuberculosis patients from California during 2008. J Public Health Manag Pract 19: 169-177. 10.1097/PHH.0b013e3182550a83 [doi]; 00124784-201303000-00010 [pii].
32. Handford CD, Rackal JM, Tynan A.M., Rzeznikiewiz D., Glazier RH (2012) The association of hospital, clinic and provider volume with HIV/AIDS care and mortality: systematic review and meta-analysis. AIDS Care 24: 267-282. 10.1080/09540121.2011.608419 [doi].
33. Honda H, Krauss MJ, Jones J.C., Olsen MA, Warren DK (2010) The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 123: 631-637. S0002-9343(10)00128-2 [pii]; 10.1016/j.amjmed.2010.01.015 [doi].
34. Jenkins TC, Price CS, Sabel A.L., Mehler PS, Burman WJ (2008) Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 46: 1000-1008. 10.1086/529190 [doi].
35. Schmitt S, McQuillen DP, Nahass R, Martinelli L., Rubin M, et al. (2013) Infectious Diseases Specialty Intervention is Associated with Decreased Mortality and Lower Healthcare Costs. Clin Infect Dis. cit610 [pii]; 10.1093/cid/cit610 [doi].
36. Davidow AL, Katz D, Reves R., Bethel J, Ngong L (2009) The challenge of multisite epidemiologic studies in diverse populations: design and implementation of a 22-site study of tuberculosis in foreign-born people. Public Health Rep 124: 391-399.
37. Mays GP, McHugh MC, Shim K, Lenaway D., Halverson PK, et al. (2004) Getting what you pay for: public health spending and the performance of essential public health services. J Public Health Manag Pract 10: 435-443.
38. Erwin PC, Greene SB, Mays G.P., Ricketts TC, Davis MV (2011) The association of changes in local health department resources with changes in state-level health outcomes. Am J Public Health 101: 609-615. AJPH.2009.177451 [pii]; 10.2105/AJPH.2009.177451 [doi].
39. World Health Organization (2010) Treatment of tuberculosis: guidelines. Geneva: WHO Press.
40. California Department of Health Services (CDHS) (2013) Medi-Cal Rates. Available at: http://files.medi-cal.ca.gov/pubsdoco/rates/rateshome.asp. Accessed on October 31, 2013.
41. Cass A, Shaw T, Ehman M., Young J, Flood JM, et al. (2013) Improved Outcomes Found After Implementing a Systematic Evaluation and Program Improvement Process for Tuberculosis. Public Health Rep 128: 367-376.
42. Curry International Tuberculosis Center (2012) Engaging the Private Sector in TB Prevention. Available at: http://www.nationaltbcenter.ucsf.edu/training/webarchive/private/arch-private.cfm. Accessed on October 31, 2013.